Penny Grabber
3 months ago
During bankruptcy proceedings, the bankrupted individual/company will have to list all assets, liabilities and income for review. This allows the courts and parties that are owed the debts to have a clear picture on they debtor's ability to pay on their defaulted obligations.
It is in the best interests of the old owners of RSHN to show the RSHN shares owned and worth very little and not liquid, as well as thrm generating little income during this period. If the RSHN common position was valued in the 100s of thousands or more, the court and parties that brought legal action against the debtor could ask the court to force a sale of the securities to pay back their debts. Being at .0002 and the total value of common being under $50,000 with very little liquidity, it shows the courts and parties who filed lawsuits it is not a viable asset for liquidation to pay down what is owed. It is my opinion that the recent filing had to be documented for the courts to review what the debtor received in the sale for the voting rights preferred A shares in RSHN. Could be wrong...but sounds right based on speculation. Considering the proceedings are still ongoing. Doubt the ticker moves higher before 2025.
Penny Grabber
3 months ago
It's been a month since the new CEO was appointed. So to expect a significant turnaround in 30 days when the stock and ticker has been beat down to .0001 by the old owners over the last 2 years is wishful thinking.
Thankfully, Congress is currently conducting an investigation (as well as supermarkets such as Walmart) pertaining to tainted shrimp imports that account for 40% of all shrimp being brought into the United States from foreign countries. In this instance, it is India.
Hopefully RSHN can ride the curtails of this situation and provide examples to Congress while it is being reviewed, as well as these Supermarkets such as Walmart, about the possibility of producing shrimp on a grand scale domestically.
Only 1% of all imported Shrimp is inspected in the US, vs. 50% in Europe. So the US is a target to distribute product with antibiotics, which is forbidden by the FDA here in the States.
Any sanctions or shift from India would create a massive gap in supply and demand of shrimp in America. Using the patented farming system licensed by RSHN could capture a massive amount of market share in the coming years to satisfy the needs of the American consumer while reducing reliance on foreign markets that are using poor working conditions, while violating human rights, and are shipping tainted, low quality, contaminated products that are arriving on kitchen tables across America.
RSHN could not ask for a better macro set up to succeed.
It will just take time to develop if management realizes the opportunity and follows the correct avenenues to present RSHN solutions for an ongoing problem nationwide.
***India accounts for roughly 2.5B usd annually of the shrimp imported in America.